Ihor W Rak

485 total citations
14 papers, 375 citations indexed

About

Ihor W Rak is a scholar working on Psychiatry and Mental health, Neurology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ihor W Rak has authored 14 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 3 papers in Neurology and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ihor W Rak's work include Schizophrenia research and treatment (8 papers), Bipolar Disorder and Treatment (3 papers) and Epilepsy research and treatment (2 papers). Ihor W Rak is often cited by papers focused on Schizophrenia research and treatment (8 papers), Bipolar Disorder and Treatment (3 papers) and Epilepsy research and treatment (2 papers). Ihor W Rak collaborates with scholars based in United States, Brazil and Japan. Ihor W Rak's co-authors include Paul Yeung, Pierre N. Tariot, Kelly Melvin, Martin Brecher, Beverly Raney, Jean B. Belasco, Donald W. Lewis, Beverly J. Lange, Roger J. Packer and Lisa A. Arvanitis and has published in prestigious journals such as Neurology, PEDIATRICS and Schizophrenia Research.

In The Last Decade

Ihor W Rak

14 papers receiving 340 citations

Peers

Countries citing papers authored by Ihor W Rak

Since Specialization

Citations

This map shows the geographic impact of Ihor W Rak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ihor W Rak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ihor W Rak more than expected).

Fields of papers citing papers by Ihor W Rak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ihor W Rak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ihor W Rak. The network helps show where Ihor W Rak may publish in the future.

Co-authorship network of co-authors of Ihor W Rak

This figure shows the co-authorship network connecting the top 25 collaborators of Ihor W Rak. A scholar is included among the top collaborators of Ihor W Rak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ihor W Rak. Ihor W Rak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Cataractogenic potential of quetiapine versus risperidone in the long-term treatment of patients with schizophrenia or schizoaffective disorder: A randomized, open-label, ophthalmologist-masked, flexible-dose, non-inferiority trial 2014 ·Journal of Psychopharmacology ·Alan M. Laties, Allan J. Flach, (unknown), Ihor W Rak, Willie Earley, Sanjeev Pathak	4
2	Quetiapine for Elderly Patients With Psychotic Disorders 2000 ·Psychiatric Annals ·Paul Yeung, Pierre N. Tariot, Lon S. Schneider, Carl Salzman, Ihor W Rak	19
3	The long-term effect of quetiapine (Seroquel TM ) monotherapy on weight in patients with schizophrenia 2000 ·International Journal of Psychiatry in Clinical Practice ·Martin Brecher, Ihor W Rak, Kelly Melvin, (unknown)	77
4	Long-term use of quetiapine in elderly patients with psychotic disorders 2000 ·Clinical Therapeutics ·Pierre N. Tariot, (unknown), Paul Yeung, (unknown), Ihor W Rak	98
5	Maintenance of long-term efficacy with ‘seroquel’ 2000 ·Schizophrenia Research ·Ihor W Rak, J. Raniwalla	5
6	Weight changes in patients treated with seroquel (quetiapine) 2000 ·Schizophrenia Research ·Ihor W Rak, (unknown), J. Raniwalla, Dung Phung, Kelly Melvin	16
7	Incidence of tardive dyskinesia is lower with quetiapine treatment than with typical antipsychotics in patients with schizophrenia and schizoaffective disorder 2000 ·Schizophrenia Research ·William M. Glazer, Hal Morgenstern, Joseph Pultz, Paul Yeung, Ihor W Rak	8
8	Incidence of Spikes and Paroxysmal Rhythmic Events in Overnight Ambulatory Computer-Assisted EEGs of Normal Subjects: A Multicenter Study 1998 ·Journal of Clinical Neurophysiology ·Steven C. Schachter, (unknown), Braxton B. Wannamaker, Ihor W Rak, Kevin H. Ruggles, (unknown), Andrew N. Wilner, (unknown), Frank Gilliam, George L. Morris, (unknown), Michael R. Sperling, Jeffrey Buchhalter, (unknown), John R. Ives, Donald L. Schomer	14
9	Medical-claims databases in the design of a health-outcomes comparison of quetiapine (`Seroquel'1Seroquel is a trademark, the property of Zeneca Limited.1) and usual-care antipsychotic medication 1998 ·Schizophrenia Research ·Walter W. Hong, Ihor W Rak, (unknown), (unknown), Jelle W. Kylstra, Herbert Y. Meltzer, William T. Carpenter, Anthony F. Lehman, Lisa A. Arvanitis	8
10	Six-month evaluation of Carbatrol (extended-release carbamazepine) in complex partial seizures 1998 ·Neurology ·Waqar Mirza, Ihor W Rak, Vijay M. Thadani, James J. Cereghino, William R. Garnett, L. M. Brown, (unknown), George Belendiuk	24
11	Overview of the efficacy of ‘seroquel’ (quetiapine) 1997 ·Schizophrenia Research ·Ihor W Rak, Lisa A. Arvanitis	4
12	The long-term efficacy and safety of ‘seroquel’ (quetiapine) 1997 ·Schizophrenia Research ·Lisa A. Arvanitis, Ihor W Rak	15
13	Efficacy, safety and tolerability of ‘seroquel’ (quetiapine) in elderly subjects with psychotic disorders 1997 ·Schizophrenia Research ·(unknown), Ihor W Rak	7
14	Incidence, Presentation, and Outcome of Spinal Cord Disease in Children With Systemic Cancer 1986 ·PEDIATRICS ·Donald W. Lewis, Roger J. Packer, Beverly Raney, Ihor W Rak, Jean B. Belasco, Beverly J. Lange	76

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact